At the CU Anschutz Health and Wellness Center, Breit counsels individuals on the importance of lifestyle in on-going clinical trials with triple agonists, experimental metabolic medications that target three receptors in the brain and body (GLP-1, GIP, and glucagon) to reduce body weight
The group was mostly women (78.6%), with an average age of 52.7
Apothecary Pharma drew an FDA warning letter on December 1, 2025 for sterile-compounding deficiencies
Every patient begins with a comprehensive evaluation to assess metabolic function, medical history, and personal goals
This page is education about the evidence and safety boundaries for does, retatrutide, show, drug, test